Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment. - Wikidata - wikimedia - TriplyDB

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

http://www.wikidata.org/entity/Q37343108

about

New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases.Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's disease.Exploring the origins of echo-time-dependent quantitative susceptibility mapping (QSM) measurements in healthy tissue and cerebral microbleeds.Cortical Iron Reflects Severity of Alzheimer's Disease.Vascular and Tissue Changes of Magnetic Susceptibility in the Mouse Brain After Transient Cerebral Ischemia.No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old.MR imaging differentiation of Fe2+ and Fe3+ based on relaxation and magnetic susceptibility properties.Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.The Aging of Iron Man.Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age.Quantitative comparison of different iron forms in the temporal cortex of Alzheimer patients and control subjects.Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration

P2860

Q37703489-B9A54588-CA24-4251-B30C-16497D987C10 Q37731606-A1125CCA-6A52-46B0-B11E-1E98DB286FDA Q38996706-FA215614-8B72-43C2-B4DB-DCF4D1489A48 Q46798456-6745CB27-DF77-4648-9316-839A9A4ECA5B Q47311988-E58450D1-9DC3-4BD5-AC13-FBF00DA1575B Q47703297-2E72E387-5715-4CA8-998C-58AE20E93E7D Q47851326-CC5EB913-6188-43D3-88E1-FDC93A3D4543 Q48097181-AE391C1D-E73F-48F3-BEAF-E7BA7055913E Q50532074-01073A24-3A3F-4B1B-829D-63550A171786 Q51758684-AB7AFFE0-BCC3-4621-996B-5DE7D2399C65 Q51762367-F8A61C5C-8164-4540-A091-D1C2ECD8AFD6 Q53513733-2E4C172C-360C-4887-BA5B-494C03EE6213 Q58696760-859A142F-5381-413C-8A04-507B83B90123 Q58754278-13361C26-1DB5-4CFC-8A53-BC26B1DAD00E Q58769184-68C90886-DD62-440D-89BD-7830D61120D9

P2860

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

http://www.wikidata.org/entity/Q37343108

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

@en

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

@nl

type

label

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

@en

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

@nl

prefLabel

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

@en

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

@nl

P1433

Q37343108-38622755-7B7D-4406-B8D8-A2C04A6BB8BA

P1476

Q37343108-851849C3-588E-49BE-BBE4-AD734C99295B

P2093

Q37343108-06090822-035A-44BC-807D-79BEAA866E06

Q37343108-0A901317-50C6-4D32-BCC3-A1B4371FCA7E

Q37343108-62A63D6F-C723-41B8-9CCD-0CE77802C7DE

Q37343108-6F07A2BF-41F2-41FC-9DF1-825C15AD2746

Q37343108-7DD9BBEE-D50E-490F-8B90-0CC545181B6D

Q37343108-83047C15-4758-45B3-9CEF-FBDCE519963F

Q37343108-9200E2D2-E8B3-4DA3-A2B4-3EA250744F0B

Q37343108-B0BE1E5B-0F3F-4BC4-97D0-EF2BD7A5199C

Q37343108-B413A152-03DD-4ED7-9910-EEE3B041AD85

Q37343108-B44332CE-55E5-44E2-9AD9-FF8427FF5F4C

P2860

Q37343108-0296F8FE-DC5A-4A18-B5A6-145F5B8D491E

Q37343108-04C031C8-A37F-437B-A88B-893473E8F93B

Q37343108-04CAF2D4-8260-4E65-9E99-2BB46AA226E3

Q37343108-0987CB15-521A-4D9A-8249-31ACE525B637

Q37343108-10D455C2-7257-4E93-A3D4-40CD0C1ED02D

Q37343108-125D80C3-A5DF-49DF-AD4C-4446D641AAA7

Q37343108-1299B6D2-5307-4C57-9D0F-DCCE90E5F11F

Q37343108-1321823B-E60E-4D51-AEC0-A5B7330D27C0

Q37343108-17C83C2D-AC1C-4782-A136-C5F7FE484436

Q37343108-1DBF770B-0F19-42F3-B9AB-D6AB5BC75B70

P2888

Q37343108-FF5280F7-7167-46F6-8113-9E29C1BDF2B8

P304

Q37343108-16C14DAE-121A-42FC-8F4E-E74E8CB4A03D

P31

Q37343108-48285F78-BE6F-431C-BB40-8613D0A4DE2F

P356

Q37343108-2BE45BFC-1AC0-43B4-9B1D-C0CF7A9DF348

P407

Q37343108-D8545A7A-B01A-4440-AB66-846208763A38

P478

Q37343108-BFB70E28-415D-4160-9D55-082710A517D2

P50

Q37343108-1EE43258-54DB-427D-8713-C8B45E20F01F

Q37343108-5C55E74B-EDA0-42BF-AD90-37AD865D5E1D

Q37343108-6886960B-BAEB-47FB-A5EB-F5D6D8A11394

Q37343108-A912F76B-AE2D-4C94-8821-52EFDD5BBE25

Q37343108-E5B3BC3D-E1D6-4189-BF7B-10685AB88E98

P577

Q37343108-FBEDED55-8DB1-47FD-80F0-D0C71165BE95

P6179

Q37343108-E1293F6F-E878-49E2-B57D-8E0161DDDBCB

P698

Q37343108-93D341C7-62BF-4556-A021-0B0E7996FD4A

P932

Q37343108-B61E250E-870B-477E-BE05-0C00328025E4

P356

P1433

Scientific Reports

P1476

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment.

@en

P2093

C Hock

http://www.w3.org/2001/XMLSchema#string

F Buck

http://www.w3.org/2001/XMLSchema#string

F C Quevenco

http://www.w3.org/2001/XMLSchema#string

J Hua

http://www.w3.org/2001/XMLSchema#string

J M G van Bergen

http://www.w3.org/2001/XMLSchema#string

K P Pruessmann

http://www.w3.org/2001/XMLSchema#string

M Wyss

http://www.w3.org/2001/XMLSchema#string

P C M van Zijl

http://www.w3.org/2001/XMLSchema#string

R M Nitsch

http://www.w3.org/2001/XMLSchema#string

S C Steininger

http://www.w3.org/2001/XMLSchema#string

P2860

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition

Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly

“Mini-mental state”

Neuropathological alterations in Alzheimer disease

The genetics of Alzheimer disease

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Mild cognitive impairment: clinical characterization and outcome

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

P2888

P304

35514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP35514

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Paul G Unschuld

Simon Schreiner

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002145731

http://www.w3.org/2001/XMLSchema#string

P698

27748454

http://www.w3.org/2001/XMLSchema#string

P932

5066274

http://www.w3.org/2001/XMLSchema#string